Pharsight

Drugs that contain Fenofibrate

1. Antara (micronized) patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7863331 LUPIN Pharmaceutical composition containing fenofibrate and method for the preparation thereof
Aug, 2020

(3 years ago)

US7101574 LUPIN Pharmaceutical composition containing fenofibrate and the preparation method
Aug, 2020

(3 years ago)

US8026281 LUPIN Treating metabolic syndrome with fenofibrate
Apr, 2025

(11 months from now)

US9314447 LUPIN Reduced dose pharmaceutical compositions of fenofibrate
May, 2033

(9 years from now)

Market Authorisation Date: 18 October, 2013

Treatment: Treating hypercholesterolemias with reduction of food effect; Treating primary hypercholesterolemia and mixed dyslipidemia; Treating severe hypertriglyceridemia

Dosage: CAPSULE;ORAL

How can I launch a generic of ANTARA (MICRONIZED) before it's drug patent expiration?
More Information on Dosage

ANTARA (MICRONIZED) family patents

Family Patents

2. Fenoglide patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9173847 SALIX Tablet comprising a fibrate
Oct, 2024

(4 months from now)

US8481078 SALIX Solid dosage form comprising a fibrate
Oct, 2024

(4 months from now)

US8124125 SALIX Solid dosage form comprising a fibrate
Oct, 2024

(4 months from now)

US7658944 SALIX Solid dosage form comprising a fibrate
Dec, 2024

(6 months from now)

Market Authorisation Date: 10 August, 2007

Treatment: Use of fenofibrate for reducing elevated total cholesterol (total-c), ldl-c, apo-lipoprotein b, or total triglycerides; For reducing total cholesterol (total-c), ldl-c, apo-lipoprotein b, or total tri...

Dosage: TABLET;ORAL

How can I launch a generic of FENOGLIDE before it's drug patent expiration?
More Information on Dosage

FENOGLIDE family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Lipofen patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5545628 CIPHER PHARMS INC Pharmaceutical composition containing fenofibrate
Jan, 2015

(9 years ago)

Market Authorisation Date: 11 January, 2006

Treatment: Treatment of hypercholesterolemia and/or hypertriglyceridemia

Dosage: CAPSULE;ORAL

More Information on Dosage

LIPOFEN family patents

Family Patents

4. Tricor patents expiration

TRICOR's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6652881 ABBVIE Fenofibrate pharmaceutical composition having high bioavailability
Jan, 2018

(6 years ago)

US6277405 ABBVIE Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it
Jan, 2018

(6 years ago)

US6589552 ABBVIE Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it
Jan, 2018

(6 years ago)

US7037529 ABBVIE Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it
Jan, 2018

(6 years ago)

US7041319 ABBVIE Fenofibrate pharmaceutical composition having high bioavailabilty
Jan, 2018

(6 years ago)

US6074670 ABBVIE Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it
Jan, 2018

(6 years ago)

US6375986 ABBVIE Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
Sep, 2020

(3 years ago)

US7320802 ABBVIE Methods of treatment using nanoparticulate fenofibrate compositions
Feb, 2023

(1 year, 2 months ago)

US7276249 ABBVIE Nanoparticulate fibrate formulations
Feb, 2023

(1 year, 2 months ago)

Market Authorisation Date: 04 September, 2001

Treatment: Adjunctive therapy to diet in adults to reduce ldl-c, total-c, triglycerides and apo b, and increase hdl-c in patients with primary hypercholesterolemia or mixed dyslipidemia (types iia, iib) and to t...

Dosage: TABLET;ORAL

How can I launch a generic of TRICOR before it's drug patent expiration?
More Information on Dosage

TRICOR family patents

Family Patents

5. Triglide patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6696084 SKYEPHARMA AG Spray drying process and compositions of fenofibrate
Sep, 2021

(2 years ago)

Market Authorisation Date: 07 May, 2005

Treatment: A method of treating dyslipidemia and dyslipoproteinemia using a dosage form that can provide an effective amount of fenofibrate to a patient in a fasted state which is at least 90% of the auc amount ...

Dosage: TABLET;ORAL

More Information on Dosage

TRIGLIDE family patents

Family Patents